- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE HealthCare Adds AI Guidance to Cardiac Ultrasound Assessments with Vscan Air SL
The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.
In order to expand access to cardiac assessments via point-of-care ultrasound, GE HealthCare has added Caption AI capability to its Vscan Air SL handheld ultrasound device.
Through Caption AI’s use of artificial intelligence (AI)-enabled guidance to assist with ultrasound probe placement and imaging, GE HealthCare said the software can promote greater confidence in the use of Vscan Air SL to perform timely cardiac evaluation, even for those clinicians who lack ultrasound expertise.
" ... Innovations like the Vscan Air SL with Caption AI are hugely transformative in cardiac care, supporting rapid and confident assessments at the point of care," said cardiologist Jordan B. Strom, M.D., MSc, an assistant professor of medicine at Harvard Medical School and director of echocardiographic research at the Beth Israel Deaconess Medical Center in Boston. (Image courtesy of GE HealthCare.)
In addition to a sector-phased array transducer, the Vscan Air SL also has an AutoEF feature, which provides automated calculation of left ventricular ejection fraction (LVEF), according to GE HealthCare.
The company suggested that the expanded capabilities of Vscan Air SL with Caption AI, which will be showcased at the American College of Cardiology (ACC) Annual Scientific Session and Expo later this week in Atlanta, could have an impact for earlier detection of heart disease in patients at resource-challenged facilities.
"With the increase of cardiovascular disease and shortage of sonographers around the globe, innovations like the Vscan Air SL with Caption AI are hugely transformative in cardiac care, supporting rapid and confident assessments at the point of care," said cardiologist Jordan B. Strom, M.D., MSc, an assistant professor of medicine at Harvard Medical School and director of echocardiographic research at the Beth Israel Deaconess Medical Center in Boston.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
